LYRA
Lyra Therapeutics, Inc. - Common Stock (LYRA)
$65
About Lyra Therapeutics, Inc. - Common Stock (LYRA)
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat (ENT) diseases. The firm's proprietary XTreo platform delivers medicines directly to targeted sites. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer on November 21, 2005 and is headquartered in Watertown, MA.
Details
Daily high
$0.65
Daily low
$0.65
Price at open
$0.65
52 Week High
$14.88
52 Week Low
$0.31
Market cap
1.0M
Dividend yield
0.00%
Volume
3,258
Avg. volume
14,802
P/E ratio
-.03
Lyra Therapeutics, Inc. - Common Stock News
Details
Daily high
$0.65
Daily low
$0.65
Price at open
$0.65
52 Week High
$14.88
52 Week Low
$0.31
Market cap
1.0M
Dividend yield
0.00%
Volume
3,258
Avg. volume
14,802
P/E ratio
-.03